Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial

Authors

Institutions

Publication Details

Journal
The Lancet
Published
2025-02-26
DOI
https://doi.org/10.1016/s0140-6736(25)00333-2
Citations
32
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
44.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial

Patricia Martínez‐Sánchez, Mona Laible, Walter E. Haefeli, Sven Poli et al.
32 citations
The Lancet
Atrial Fibrillation Management and Outcomes
44.42
article

Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial

Patricia Martínez‐Sánchez, Mona Laible, Walter E. Haefeli, Sven Poli, Deirdre A. Lane, Jan Purrucker, Viktoria S. Wurmbach, Morgane Lachaize, Kathrin I. Foerster, Valeria Caso, Peter Brønnum Nielsen, Christian Enzinger, Karim Hajjar, Carolin Schuhmann, Yolanda Silva, Peter U. Heuschmann, Lucio D’Anna, Marion Boulanger, Omid Halse, Viktoria Rücker, Roland C. Veltkamp, Simon Fandler‐Höfler, Peter A. Ringleb, Maria Giulia Mosconi, Joan Montaner, Cornelia Fießler, Sabine Ullmann, Guillaume Paré, Hatem A Wafa, Uwe Malzahn, Gabriele Putz Todd, Kirsten Haas, Charles D.A. Wolfe, Stefan Ropele, Bo Norrving, Virginia Cancelloni, George Ntaios, Elena Palà, Stéphanie Debette, Igor Sibon, Reyes de Torres Chacón, Yanzhong Wang, Melanie Haidegger, Rolf Wachter, Tim D’Aoust, Patrick Müller, Kirsten Harvey, Emily R. Harvey, Eleni Korompoki, Klemens Hügen, Gregory Y H Lip
article en
32 citations

Abstract

No abstract available for this paper.
The LancetVol. 405(10482)
Université de Bordeaux (FR), King's College London (GB), Universität Ulm (DE), Medical University of Graz (AT), Aristotle University of Thessaloniki (GR), Heidelberg University (DE), University of Würzburg (DE), University Hospital Heidelberg (DE), Hospital Universitario Virgen Macarena (ES), Bordeaux Population Health (FR), University Hospital Leipzig (DE), Universitätsklinikum Würzburg (DE), Skåne University Hospital (SE), Alfried Krupp Hospital (DE), Imperial College London (GB), Université de Caen Normandie (FR)
Amgen, Pfizer, AstraZeneca, Sanofi, Alexion Pharmaceuticals, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Imperial College London, European Commission, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Daiichi-Sankyo, Deutsche Herzstiftung, Deutsche Krebshilfe, University of Thessaly, Servier, Gemeinsame Bundesausschuss, Universitätsklinikum Heidelberg, Robert Koch Institut, Horizon 2020, Daiichi Sankyo Europe
Good health and well-being
Openalex Percentile: Top 0%
Atrial Fibrillation Management and Outcomes
44.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.